|
Volumn 5, Issue 1, 2014, Pages 9-10
|
Spherical nucleic acids for precision medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GADOLINIUM;
GOLD NANOPARTICLE;
MESSENGER RNA;
NANOCONJUGATE;
PROTEIN BCL 2;
PROTEIN BCL 2 LIKE 12;
RNA INDUCED SILENCING COMPLEX;
SHORT HAIRPIN RNA;
SMALL INTERFERING RNA;
SPHERICAL NUCLEIC ACID;
UNCLASSIFIED DRUG;
GOLD;
METAL NANOPARTICLE;
NUCLEIC ACID;
AMINO ACID SEQUENCE;
APOPTOSIS;
BLOOD BRAIN BARRIER;
CANCER GENETICS;
CANCER PROGNOSIS;
CENTRAL NERVOUS SYSTEM DISEASE;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SAFETY;
DRUG TARGETING;
DRUG TUMOR LEVEL;
EDITORIAL;
ENDOCYTOSIS;
GENE DOSAGE;
GENE EXPRESSION;
GENE MUTATION;
GENE SILENCING;
GENETIC STABILITY;
GENETIC TRANSFECTION;
GENOTYPE;
GLIOBLASTOMA;
HUMAN;
NANOTECHNOLOGY;
NONHUMAN;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
RNA INTERFERENCE;
ANIMAL;
CHEMISTRY;
CONFORMATION;
GENE THERAPY;
PERSONALIZED MEDICINE;
PROCEDURES;
ANIMALS;
GENETIC THERAPY;
GOLD;
HUMANS;
INDIVIDUALIZED MEDICINE;
METAL NANOPARTICLES;
NANOCONJUGATES;
NANOTECHNOLOGY;
NUCLEIC ACID CONFORMATION;
NUCLEIC ACIDS;
|
EID: 84893870020
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.1757 Document Type: Editorial |
Times cited : (5)
|
References (9)
|